Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gold

Showing results (891-900 of 1,272) with videos related to

Pageof 128
Sort By:
Schizophrenia Bulletin|July 26, 2015
Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2—External Validity and CorrelatesWilliam P Horan, L Felice Reddy, Deanna M Barch, et al.
Biology of Sex Differences|August 30, 2020
Sex differences in brain atrophy in multiple sclerosisRhonda R Voskuhl, Kevin Patel, Friedemann Paul, et al.
Nature Communications|December 1, 2022
Electron cryo-microscopy reveals the structure of the archaeal thread filamentMatthew C Gaines, Michail N Isupov, Shamphavi Sivabalasarma, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 7, 2022
Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the artEvelien Van Assche, J Antoni Ramos-Quiroga, Carmine M Pariante, et al.
Schizophrenia Bulletin|November 22, 2011
Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia ConsortiumJames M Gold, Deanna M Barch, Cameron S Carter, et al.
Physical Review Letters|November 3, 2001
Temperature measurements of shock compressed liquid deuterium up to 230 GPaG W Collins, P M Celliers, L B Da Silva, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Membrane protein insertion and proton-motive-force-dependent secretion through the bacterial holo-translocon SecYEG-SecDF-YajC-YidCRyan J Schulze, Joanna Komar, Mathieu Botte, et al.
The Journal of Clinical Psychiatry|April 11, 2009
A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophreniaDeanna L Kelly, Robert W Buchanan, Douglas L Boggs, et al.
Schizophrenia Research|November 7, 2012
Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom ScaleGregory P Strauss, William R Keller, Robert W Buchanan, et al.
Frontiers in Neurology|August 5, 2021
Arm Ergometry to Improve Mobility in Progressive Multiple Sclerosis (AMBOS)-Results of a Pilot Randomized Controlled TrialInga Heinrich, Friederike Rosenthal, Stefan Patra, et al.
Pageof 128

Showing results (891-900 of 1,272) with videos related to

Sort By:
Pageof 128
Schizophrenia Bulletin|July 26, 2015
Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2—External Validity and CorrelatesWilliam P Horan, L Felice Reddy, Deanna M Barch, et al.
Biology of Sex Differences|August 30, 2020
Sex differences in brain atrophy in multiple sclerosisRhonda R Voskuhl, Kevin Patel, Friedemann Paul, et al.
Nature Communications|December 1, 2022
Electron cryo-microscopy reveals the structure of the archaeal thread filamentMatthew C Gaines, Michail N Isupov, Shamphavi Sivabalasarma, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 7, 2022
Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the artEvelien Van Assche, J Antoni Ramos-Quiroga, Carmine M Pariante, et al.
Schizophrenia Bulletin|November 22, 2011
Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia ConsortiumJames M Gold, Deanna M Barch, Cameron S Carter, et al.
Physical Review Letters|November 3, 2001
Temperature measurements of shock compressed liquid deuterium up to 230 GPaG W Collins, P M Celliers, L B Da Silva, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Membrane protein insertion and proton-motive-force-dependent secretion through the bacterial holo-translocon SecYEG-SecDF-YajC-YidCRyan J Schulze, Joanna Komar, Mathieu Botte, et al.
The Journal of Clinical Psychiatry|April 11, 2009
A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophreniaDeanna L Kelly, Robert W Buchanan, Douglas L Boggs, et al.
Schizophrenia Research|November 7, 2012
Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom ScaleGregory P Strauss, William R Keller, Robert W Buchanan, et al.
Frontiers in Neurology|August 5, 2021
Arm Ergometry to Improve Mobility in Progressive Multiple Sclerosis (AMBOS)-Results of a Pilot Randomized Controlled TrialInga Heinrich, Friederike Rosenthal, Stefan Patra, et al.
Pageof 128